Benefit –risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials

British Journal of Dermatology, EarlyView.

Source: British Journal of Dermatology - October 11, 2018 Category: Dermatology Authors: B.E. Strober, A.B. Gottlieb, P.C.M. Kerkhof, L. Puig, H. Bachelez, E. Chouela, S. Imafuku, D. Tha çi, H. Tan, H. Valdez, P. Gupta, M. Kaur, V. Frajzyngier, R. Wolk Source Type: research